Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers products for the treatment of analgesic and gastro-intestinal problems, sore throat, cough, pain, and flu, as well as wellness products in sexual wellbeing, footcare, vitamins, and supplements under the Durex, Gaviscon, Nurofen, Mucinex, Scholl/Amopé, and Strepsils brand names.
Read More…
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
CIKN/A
WebN/A
PhoneN/A
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees42,400
Next Earnings Date2/17/2020 (Estimated)
OptionableNot Optionable
RECKITT BENCKIS/S (OTCMKTS:RBGLY) Frequently Asked Questions
What is RECKITT BENCKIS/S's stock symbol?
RECKITT BENCKIS/S trades on the OTCMKTS under the ticker symbol "RBGLY."
When is RECKITT BENCKIS/S's next earnings date?
What is the consensus analysts' recommendation for RECKITT BENCKIS/S?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RECKITT BENCKIS/S in the last year. There are currently 1 sell rating, 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for RECKITT BENCKIS/S.
Has RECKITT BENCKIS/S been receiving favorable news coverage?
Media coverage about RBGLY stock has trended somewhat positive on Sunday, according to InfoTrie. The research firm ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. RECKITT BENCKIS/S earned a news sentiment score of 0.8 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for RECKITT BENCKIS/S.
What other stocks do shareholders of RECKITT BENCKIS/S own?
Who are RECKITT BENCKIS/S's key executives?
RECKITT BENCKIS/S's management team includes the folowing people:
- Mr. Rakesh Kapoor, Group CEO & Director (Age 60)
- Mr. Adrian Nevil Hennah, CFO & Director (Age 62)
- Mr. Aditya Sehgal, Chief Operating Officer of Health
- Mr. Seth Cohen, Chief Information Officer
- Mr. Richard Joyce, Sr. VP of Investor Relations
How do I buy shares of RECKITT BENCKIS/S?
Shares of RBGLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is RECKITT BENCKIS/S's stock price today?
One share of RBGLY stock can currently be purchased for approximately $16.84.
MarketBeat Community Rating for RECKITT BENCKIS/S (OTCMKTS RBGLY)
MarketBeat's community ratings are surveys of what our community members think about RECKITT BENCKIS/S and other stocks. Vote "Outperform" if you believe RBGLY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RBGLY will underperform the S&P 500 over the long term. You may vote once every thirty days.
